Suppressing FAT1 expression promoted the phosphorylation of CaMKII and restrained the formation of the p-STAT1/IRF9 complex, resulting in deactivation of the interferon pathway and enhancement of the malignant phenotype of HNSCC. The gene discussed is IRF9; the disease is head and neck squamous cell carcinoma.